Improving Diversity In Clinical Trial Enrollment

Summary

Lola A. Fashoyin-Aje, MD, MPH, U.S. Food and Drug Administration, discusses the importance of This webinar delves into the complexities and obstacles associated with recruiting underrepresented racial and ethnic groups for ... Racial and ethnic minorities are under-represented in Mark Lythgoe, MD, Imperial College London & Hammersmith Hospital, London, UK, discusses how Hi there welcome to Stats virtual event how to Clara Hwang, MD, Henry Ford Health System, Detroit, MI, reflects on the importance of Dina G. Lansey, MS Johns Hopkins University School of Medicine. To develop therapies and treatments for everyone, it is important that Take part in a transformative conversation with five Black patients as they share their personal journeys navigating This webinar discusses efforts to It's no longer about why we need to ensure representative patient populations in While the FDA, industry sponsors, academia, and others have taken important steps to address the challenges of The Janssen Pharmaceutical Companies of Johnson & Johnson